These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 5534721
1. [On uptake of 5-FU, 6-MP and methotrexate by ehrlich ascites tumor cells in vitro]. Oriuchi T. Sapporo Igaku Zasshi; 1970 Jun; 37(6):255-67. PubMed ID: 5534721 [No Abstract] [Full Text] [Related]
2. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro. Gotto AM, Belkhode ML, Touster O. Cancer Res; 1969 Apr; 29(4):807-11. PubMed ID: 5775710 [No Abstract] [Full Text] [Related]
3. [Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma]. Shlemkevich MP. Biull Eksp Biol Med; 1983 Feb; 95(2):72-4. PubMed ID: 6824782 [Abstract] [Full Text] [Related]
5. Amethopterin transport in Ehrlich ascites carcinoma and L1210 cells. Kessel D, Hall TC. Cancer Res; 1967 Sep; 27(9):1539-43. PubMed ID: 6051269 [No Abstract] [Full Text] [Related]
6. Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumor. White JC, Carchman RA, Fry DW, Goldman ID. Cancer Res; 1980 Jul; 40(7):2400-4. PubMed ID: 6155994 [Abstract] [Full Text] [Related]
7. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2. Nagai K, Nagasawa K, Kihara Y, Okuda H, Fujimoto S. Int J Pharm; 2007 Mar 21; 333(1-2):56-61. PubMed ID: 17088032 [Abstract] [Full Text] [Related]
8. [Pharmacokinetics of fluoropyrimidines]. Fujita H. Gan To Kagaku Ryoho; 1984 Nov 21; 11(11):2307-15. PubMed ID: 6437341 [Abstract] [Full Text] [Related]
9. [Effect of ascorbic acid on incorporation of 5-fluorouracil-6-3H into acid-soluble fraction and into RNA of sensitive and resistant to 5-fluorouracil cells of Ehrlich ascites carcinoma]. Shlemkevich MP. Biull Eksp Biol Med; 1982 Feb 21; 93(2):56-7. PubMed ID: 7066528 [No Abstract] [Full Text] [Related]
10. [Experimental studies on the uptake of anticancer drugs in cancer cells in hyperthermochemotherapy--effects of in vitro and in vivo heating on the uptake of 5-fluorouracil in Ehrlich cells]. Yamane T. Nihon Geka Gakkai Zasshi; 1986 Mar 21; 87(3):254-65. PubMed ID: 3713678 [Abstract] [Full Text] [Related]
11. [Effects of "cell membrane-acting" substances on uptake of anticancer chemotherapeutics by tumor cells--with special reference to mitomycin C uptake by Ehrlich ascites tumor cells in vitro--]. Ishikawa M. Sapporo Igaku Zasshi; 1969 Apr 21; 35(4):251-64. PubMed ID: 5393533 [No Abstract] [Full Text] [Related]
12. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. Fry DW, Anderson LA, Borst M, Goldman ID. Cancer Res; 1983 Mar 21; 43(3):1087-92. PubMed ID: 6186369 [No Abstract] [Full Text] [Related]
13. The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice. Fung KP, Ng SW, Choy YM. Cancer Biochem Biophys; 1986 Oct 21; 8(4):249-56. PubMed ID: 3802046 [Abstract] [Full Text] [Related]
14. The effect of heparin on the cytotoxicity and uptake of anti-neoplastic drugs in cultured Burkitt lymphoma cells. Wheeler RH, Bull FE, Ruddon RW. Cancer Res; 1974 Dec 21; 34(12):3215-9. PubMed ID: 4429950 [No Abstract] [Full Text] [Related]
15. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells. Goldman ID, Fyfe MJ. Mol Pharmacol; 1974 Mar 21; 10(2):275-82. PubMed ID: 4859543 [No Abstract] [Full Text] [Related]
16. A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro. Bowen D, White JC, Goldman ID. Cancer Res; 1978 Jan 21; 38(1):219-22. PubMed ID: 618577 [Abstract] [Full Text] [Related]
17. Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro. Gewirtz DA. Cancer Res; 1985 Dec 21; 45(12 Pt 1):6290-2. PubMed ID: 4063980 [Abstract] [Full Text] [Related]
18. Effect of in vivo treatment with L-asparaginase on the in vitro uptake and phosphorylation of some antileukemic agents. Nahas A, Capizzi RL. Cancer Res; 1974 Oct 21; 34(10):2689-93. PubMed ID: 4413062 [No Abstract] [Full Text] [Related]
19. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. Goldman ID. Biochim Biophys Acta; 1971 Jun 01; 233(3):624-34. PubMed ID: 5113921 [No Abstract] [Full Text] [Related]
20. [5'-desoxy-5'-fluorothymidine, a new inhibitor of the DNA synthesis]. Langen P, Kowollik G. Acta Biol Med Ger; 1968 Jun 01; 20(3):417-9. PubMed ID: 5755159 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]